TG Therapeutics | TGTX - 流动负债



金融业
股票价格
USD
资产
USD 1.53B
现金及等价物
USD 442.21M
销售成本
USD 33.51M
流动资产
USD 1.09B
流动负债
USD 187.11M
债务
USD 253.71M
EBIT
USD 34.8M
EBITDA
USD 51.69M
员工
338
EPS每股收益
USD 0.12
股本和储备
USD 583.13M
销售毛利
USD 171.41M
债务利息支出
USD 7.67M
贷款资金
USD 745.14M
市值
USD 6B
净收入
USD 19.78M
营业费用
USD 170.12M
营业利润
USD 34.8M
普通股股本
USD 155.31M
PE价格收益
10.76
税前利润
USD 20.36M
销售收入
USD 194.8M
销售和管理费用
USD 73.14M
股票
USD 129.03M
贸易债权人
USD 148.85M
应收帐款人
USD 392.05M


流动负债 更改 日
AbbVie USD 42.1B 1.19B 2026-03
Alaunos Therapeutics USD 595K 218K 2026-03
Amgen USD 24.96B 534M 2026-03
Ardelyx USD 109.57M 20.96M 2026-03
Arrowhead Research USD 295.22M 52.2M 2026-03
Bayer EUR 33.46B 875M 2026-03
Biogen USD 3B 350.5M 2026-03
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Curis USD 14.08M 5.3M 2025-12
Gilead Sciences USD 9.48B 2.34B 2026-03
Infinity Pharmaceuticals USD 12.06M 775K 2023-06
J&J USD 57.72B 3.59B 2026-03
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Novavax USD 342.46M 117.49M 2026-03
PTC Therapeutics USD 923.6M 44.82M 2026-03
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Roche Holding CHF 28B 421M 2025-12
TG Therapeutics USD 187.11M 33.35M 2026-03
Verastem USD 72.27M 12.56M 2025-12
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03